Bacterial Infection As a Cause of Cancer

Total Page:16

File Type:pdf, Size:1020Kb

Bacterial Infection As a Cause of Cancer CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Bacterial Infection as a Cause of Cancer Julie Parsonnet Departments of Medicine and Health Research and Policy, Stanford University School of Medicine, Stanford, California Bacterial infections traditionally have not been considered major causes of cancer. Recently, however, bacteria have been linked to cancer by two mechanisms: induction of chronic inflammation and production of carcinogenic bacterial metabolites. The most specific example of the inflammatory mechanism of carcinogenesis is Helicobacter pylori infection. H. pylori has been epidemiologically linked to adenocarcinoma of the distal stomach by its propensity to cause lifelong inflammation. This inflammation is in turn thought to cause cancer by inducing cell proliferation and production of mutagenic free radicals and N-nitroso compounds. H. pylori is the first bacterium to be termed a definite cause of cancer in humans by the International Agency for Research on Cancer. Mutagenic bacterial metabolites are also suspected to increase risk for cancer. This model is best exemplified in colon cancer. Bile salt metabolites increase colonic cell proliferation. Exogenous compounds such as rutin may be metabolized into mutagens by resident colonic flora. Moreover, Bacteroides species can produce fecapentaenes, potent in vitro mutagens, in relatively high concentrations. In vivo data on human carcinogenesis by bacterial metabolites, however, are inconsistent. Local bacterial infections may also predispose to nonnodal lymphomas, although the mechanisms for this are unknown. Gastric lymphomas and immunoproliferative small intestinal disease have been most strongly linked to underlying bacterial infection. Because bacterial infections can be cured with antibiotics, identification of bacterial causes of malignancy could have important implications for cancer prevention. - Environ Health Perspect 1 03(Suppl 8):263-268 (1995) Key words: bacteria, neoplasm, gastric cancer, colorectal cancer, Helicobacterpylori, epidemiology, carcinogenesis, normal flora Introduction link between active tuberculosis and chronic osteomyelitis was the first to be A substantial number of bacterial pathogens malignancy is currently ascribed to reacti- convincingly associated with cancer in have been putatively linked to cancer. As vation of infection in immunocompro- humans. Constant irritation of a draining early as 1772, Mycobacterium tuberculosis mised cancer patients rather than to a sinus tract by inflammatory exudates of the was thought to cause malignancy (1). It cause-and-effect relationship between underlying bone predisposes the host to was observed that bronchogenic carcinomas infection and neoplasm (2-4). carcinoma of the skin, regardless of the frequently appeared in areas of pulmonary Despite this early misstep, bacterial specific bacterial pathogen involved (9). scarring, presumably from tuberculosis. theories for carcinogenesis continue to be Fortunately, in the era of antibiotics Persons with lung cancer also were noted promulgated (5). Now, however, rather chronic osteomyelitis contributes a vanish- to have active tuberculosis more frequently than directly attributing cancer to specific ingly small number of cases to the cancer than the general population. Like many organisms, attention has focused on non- registry. A similar mechanism has been hypotheses attributing cancer to specific specific mechanisms of carcinogenesis. proposed for bladder cancer in persons infectious agents, however, the tuber- Two such mechanisms are induction of with recurrent or persistent cystitis (10,11). culosis-cancer theory did not stand the test inflammation, and production of muta- Currently, a popular model for bacterial of time. Most bronchogenic carcinomas in genic compounds by bacterial metabolism. carcinogenesis is that of Helicobacter pylori persons with tuberculosis do not occur at The first mechanism is best exemplified by infection and gastric adenocarcinoma. H. scar sites but elsewhere in the lung. Helicobacter pylori infection and gastric pylori is a Gram-negative rod that lives in a Furthermore, observed scars at tumor cancer. Colon cancer provides a model for neutral pH niche between the mucus layer sites now appear to be the result of the the second of these mechanisms. Yet a of the stomach and the gastric epithelium. malignancy rather than the cause. Any third mechanism, that for lymphomas, has Although H. pylori can be found lining the yet to be credibly modeled. mucus layer adjacent to ectopic gastric tis- Bacteria, Inflammation, and sue (e.g., in Meckel's diverticula), it is never This paper was presented at the President's found remote from gastric epithelium and Cancer Panel Conference on Avoidable Causes of Cancer: the Helicobacterpylori does not invade tissue; it neither enters Cancer held 7-8 April 1994 in Bethesda, Maryland. Model epithelial cells nor penetrates the basement Manuscript received 9 March 1995; manuscript accepted 24 March 1995. Infections have been nonspecifically tied to membrane. Despite this lack of invasion, This work is supported in part by a Junior Faculty malignancy through their ability to cause H. pylori infection is invariably associated Research Award from the American Cancer Society chronic inflammation. Among the chronic with inflammation (12,13). Once estab- and by a Clinical Epidemiology Fellowship from Merck and the Society for Epidemiologic Research. inflammatory processes linked to cancer are lished, H. pylori infection and its associated Address correspondence to Dr. Julie Parsonnet, parasitic infections [e.g., Schistosoma inflammation are thought to last for Departments of Medicine and Health Research and haematobium and Opisthorchis viverrini decades if not a lifetime (14). At least 50% Policy, HRP Building, Room 225, Stanford University and viruses B In gen- of the world's harbors the School of Medicine, Stanford, CA 94305. Telephone: (6,7)] [hepatitis (8)]. population (415) 723-7274. Fax: (415) 725-6951. E-mail: eral, these infections cause cancer in direct organism (14). [email protected] proportion to their chronicity; the longer Recently, H. pylori was declared by the Abbreviations used: IPSID, immunoproliferative the inflammatory process persists, the more International Agency for Research on small intestinal disease; MALT, mucosal-associated lymphoid tissue; IARC, International Agency for likely malignancy is to develop (7,8). Cancer (IARC) to be a Group 1 carcino- Research on Cancer. Among bacterial inflammatory processes, gen, a definite cause of human cancer (7). Environmental Health Perspectives 263 J. PARSONNET Support for this decision came principally case-control studies of H. pylori in gastric damage to the epithelium by the inflamma- from pathologic studies of the natural his- cancer have shown significant associations tory response (49,53-57). Cell proliferation tory of gastric adenocarcinoma and epi- between infection and malignancy (32-35), in turn increases risk for DNA replication demiologic studies statistically linking H. others have not (36-40). error and predisposes mucosal cells to pylori to malignancy. The most convincing data implicating transformation by dietary or endogenous Chronic superficial gastritis has long H. pylori as a cause of cancer are four mutagens (58,59). been thought to be a precursor lesion to nested case-control studies from Hawaii, Other elements of inflammation also gastric adenocarcinoma (15,16). Even in California, Great Britain, and Taiwan can be seen as tumor-promoting processes the absence of more advanced preneoplas- (41-44). In the first three studies (mean (48,58). Inflammatory cells increase con- tic lesions, superficial gastritis increases follow-up 13, 14, and 6 years, respec- version of nitrates to nitrites, enhancing the cancer risk 2-fold (17). In approximately 3 tively), serologic evidence of H. pylori likelihood of N-nitrosamine formation (6). to 5% of persons per year, superficial gas- infection increased risk of later developing This may explain the epidemiologic obser- tritis progresses to chronic atrophic gastri- gastric cancer between 2.8- and 6-fold vation that in some populations high tis, a more advanced cancer precursor (41-43). The fourth nested case-control dietary nitrates increase gastric cancer risk lesion (18-20). With extensive atrophy, study also identified an elevated risk of (60). Moreover, activated macrophages cancer risk increases up to 9-fold (17). As cancer (odds ratio = 1.6), but the finding produce nitrite, nitrate, and nitrosating atrophy worsens, patches of intestinal was not statistically significant (44). This agents (61). When macrophages are cul- metaplasia arise and the gastric epithelium last study was hampered, however, by a tured with appropriate amines, N-nitroso transforms to either small or large bowel small number of cases (n = 29) and short compounds are formed. Free radicals pro- morphology. Cancer ensues thereafter. follow-up period (mean = 3 years). Overall, duced by the inflammatory response, e.g., Since H. pylori causes the vast majority the association between H. pylori and 0- and superoxide, alter the structure and of superficial gastritis, it can be deduced cancer appeared to be restricted to tumors function oflipids, proteins, and DNA caus- from the data above that H. pylori is a distal to the gastric cardia (41,43). ing changes in cell metabolism and gene likely risk factor for malignancy and A combined analysis of three nested
Recommended publications
  • Cancer Prevention Works. Reliable. Trusted. Scientific
    The work of CDC in 2018 included innovative communication approaches to promote cancer prevention, screening and early detection, research, and evidence-based programs. Achieving Progress in Programs CDC’s National Comprehensive Cancer Control Program CDC’s Colorectal Cancer Control Program (CRCCP) supported (NCCCP) celebrated 20 years of providing guidance to help 30 state, university, tribal organization grantees partnering programs put sustainable plans in action to prevent and with health systems to increase colorectal cancer screening in control cancer. More than 98,000 people have contributed high-need populations. For the 413 clinics enrolled in program to cancer coalitions and 69 cancer plans have been created year 1, screening rates increased 8.3 percentage points by the and updated. end of program year 2. Improving and Connecting Data to Prevention Through the National Program of Cancer Registries (NPCR), data is now available for cancer prevalence and survival rates, along with incidence and mortality data at the national, state, and county level. Data can be easily and quickly viewed in multiple formats using our new interactive data visualization tool. Publications: Using Data to Inform Prevention Strategies Uterine cancer incidence and death rates increased among women in United States from 1999–2016. (Morbidity and Mortality Weekly Report (MMWR)). CDC’s skin cancer prevention study demonstrates that state indoor tanning laws work as policy interventions to reduce indoor tanning behavior among adolescents. (American Journal of Public Health (AJPH)). Study results showed that the nation achieved the Healthy People 2020 target to reduce indoor tanning prevalence to 14% among CDC’s human papillomavirus adolescents in (HPV) study shows increasing grades 9 through rates of new HPV-associated 12, several years cancers among men and ahead of time.
    [Show full text]
  • Principles of Cancer Prevention and Will Emphasize the Scientific Underpinnings of This Emerging Discipline
    Seminars in Oncology Nursing, Vol 21, No 4 (November), 2005: pp 229-235 229 OBJECTIVE: To summarize the scientific prin- ciples underlying cancer preven- tion. PRINCIPLES OF DATA SOURCES: Articles, text books, personal com- CANCER munications, and experience. CONCLUSION: PREVENTION The scientific basis of cancer pre- vention is complex and involves experimental and epidemiologic approaches and clinical trials. FRANK L. MEYSKENS,JR AND PATRICIA TULLY IMPLICATIONS FOR NURSING PRACTICE: ANCER prevention has classically encompassed As more information becomes three large areas of clinical practice: prevention, available regarding proven and screening, and early detection. Several excellent potential cancer-prevention strate- reviews and book chapters have been published gies, oncology nurses are regu- involving these topics.1-3 The importance of bio- larly called upon to guide patients Clogical and molecular markers as potential surrogates have been and others in making choices re- emphasized in the past several years,4,5 and more recently precan- garding preventative options. It is cers or intraepithelial neoplasia (IEN) have become a target.6,7 The important for oncology nurses to integration of the well-established approaches of prevention, stay abreast of this growing body screening, and early detection with biological measures of disease of knowledge. risk, progression, and prognosis has become the hallmark of mod- ern cancer prevention (see Fig 1). In this article we will review the principles of cancer prevention and will emphasize the scientific underpinnings of this emerging discipline. The principles of cancer prevention have evolved from three separate scientific disciplines: carcinogenesis, epidemiology, and clinical trials. Many other areas From the Department of Medicine and of science and medicine, including genetics and the behavioral Biological Chemistry, Chao Family Com- sciences, are contributing to this evolving and complex field.
    [Show full text]
  • 9Ways to Reduce Your Cancer Risk
    9 ways to reduce your cancer risk Up to half of cancer cases in the United States could be prevented through healthy lifestyle behaviors. Maintain a healthy weight Being overweight or obese increases your risk for certain cancers, including uterine, colorectal and post-menopausal breast cancer. Eat a plant-based diet Fill 2/3 of your plate with vegetables, fruits and whole grains. Fill the remaining 1/3 with lean animal protein or plant-based protein. Limit red meat and processed meat. Stay active Sit less. Aim for at least 150 minutes of moderate or 75 minutes of vigorous physical activity each week. Do muscle-strengthening exercises at least twice a week. Don’t smoke or use tobacco If you do smoke, quit by using a program that includes a combination of medications, nicotine replacement like patches or gum, and counseling. Vaping has not been proven as a safe alternative to smoking or as a smoking cessation tool. Limit alcohol For cancer prevention, it’s best not to drink alcohol. It is linked to several cancers, including breast, colorectal and liver cancer. Get vaccinated All males and females ages 9–26 should get the HPV vaccine. It is most effective when given at ages 11–12. Unvaccinated men and women ages 27–45 should talk to their doctor about the benefits of the vaccine. Children and adults should be vaccinated against hepatitis B. Get screened Screening exams can find cancer early, when it is most treatable. They also find viruses that increase your cancer risk. Ask your doctor about screening exams for you based on your age, gender and risk factors.
    [Show full text]
  • Cancer: an Evolutionary Perspective
    Central Journal of Cancer Biology & Research Case Report *Corresponding author Rajdeep Chowdhury, Department of Biological Sciences, Birla Institute of Technology and Science Cancer: An Evolutionary (BITS), Pilani, Rajasthan 333031, India, Tel: 91- 1596515608; Email: Perspective Submitted: 25 June 2015 Jyothi Nagraj, Sudeshna Mukherjee and Rajdeep Chowdhury* Accepted: 29 July 2015 Department of Biological Sciences, Birla Institute of Technology and Science, India Published: 31 July 2015 Copyright Abstract © 2015 Chowdhury et al. Cancer is intricately linked to our evolutionary history. The origin and progression OPEN ACCESS of cancer can hence be better understood when viewed from an evolutionary perspective. In this review, we portray the fundamental fact that within the complex Keywords ecosystem of the human body, the cancerous cells also evolve. Just like any organism, • Cancer they face diverse selective pressure to adapt to the tumor environment. There exists • Evolution a competitive struggle that eliminates the unfit, leaving the well-adapted to thrive. • Natural selection Sequential acquisition of “driver mutations”, chromosomal instability triggering macro- • Macro-mutation mutations and punctuated bursts of genetic changes can all hypothetically contribute • Atavism to the origin and evolution of cancer. We further describe that like in any ecosystem, • Antagonistic pleiotropy cancer evolution involves not just the cancerous cells but also its interaction with the • Cannibalism environment. However, as cancer evolves, individual cells behave more like a uni- • Contagious cancer cellular organism focused on its own survival. We also discuss evidences where cancer has evolved through transmission between individuals. An evolutionary analogy can open up new vistas in the treatment of this dreadful disease. ABBREVIATIONS of the human body, cells tend to accumulate mutations over time as they react to the changing tissue environment.
    [Show full text]
  • (WHO). Cancer Control: Knowledge Into Action
    The World Health Organization estimates that 7.6 million people died of cancer in 2005 and 84 million people will die in the next 10 years if action is not taken. Cancer Control More than 70% of all cancer deaths occur in low and middle income countries, where resources available for prevention, diagnosis and treatment of cancer are Knowledge into Action limited or nonexistent. WHO Guide for Effective Programmes Yet cancer is to a large extent avoidable. Over 40% of all cancers can be prevented. Some of the most common cancers are curable if detected early and treated. Even with late cancer, the suffering of patients can be relieved with good palliative care. Cancer control: knowledge into action: WHO guide for effective programmes is a series of six modules offering guidance on all important aspects of effective cancer control planning and implementation. This second module, Prevention, provides practical advice for programme managers in charge of developing or scaling up cancer prevention activities. It shows how to implement cancer prevention by controlling major avoidable cancer risk factors. It also recommends strategies for establishing or strengthening cancer prevention programmes. Using this Prevention module, programme managers in every country, regardless of resource level, can confi dently take steps to curb the cancer epidemic. They can save lives and prevent unnecessary suffering caused by cancer. ISBN 92 4 154711 1 Prevention Cancer Control Knowledge into Action WHO Guide for Effective Programmes Prevention WHO Library Cataloguing-in-Publication Data Prevention. (Cancer control : knowledge into action : WHO guide for effective programmes ; module 2.) 1.Neoplasms – prevention and control.
    [Show full text]
  • Nutrition and Cancer Prevention No Single Food Or Food Component Can Protect You Against Cancer by Itself, but a Diet Filled with Think About
    Nutrition and Cancer Prevention No single food or food component can protect you against cancer by itself, but a diet filled with Think about . a variety of vegetables, fruits, whole grains, beans and other plant foods helps lower risk for • Eating foods mostly from plants many cancers. Many individual minerals, vitamins, and phytochemicals demonstrate anti-cancer effects. Evidence suggests it is the synergy of compounds in the overall diet that offers the • How much food you are eating strongest cancer protection, so eating a variety of foods from all foods groups is recommended. • Being physically active The most important thing you can do to prevent cancer is maintain a healthy body weight. • Maintaining a healthy weight Eat More of these Foods Eat Less of these Foods Fiber: Dietary fiber is linked with a lower risk of some Alcohol: Ethanol, the alcohol found in drinks, is a recognized types of cancer, especially colorectal cancer. Sources of carcinogen that may lead to DNA damage and increased risk of fiber include beans, whole grains, brown rice, popcorn, nuts cancer. People who drink alcohol should limit their intake to no (such as almonds, pecans, and walnuts), baked potatoes more than three drinks per week. A drink is defined as 12 ounces with skin, berries, bran cereal and oatmeal. Increase fiber in of beer, 5 ounces of wine, or 1½ ounces of hard liquor. your diet slowly to avoid constipation, abdominal cramping Meat: Some studies have linked eating large amounts of and excess gas. processed meat and red meat to an increased risk of cancer.
    [Show full text]
  • SKIN CANCER FACTS with STATISTICS Don’T Fry Day
    www.skincancerprevention.org SKIN CANCER FACTS with STATISTICS Don’t Fry Day • Skin cancer is the most common form of cancer in the United States. More than 3.5 million new cases of skin cancers are diagnosed in more than 2.2 million people annually.1 • It is estimated that one American dies every hour from skin cancer.2 • Each year there are more new cases of skin cancer than the comBined incidence of cancers of the breast, prostate, lung and colon.3 • One in five Americans will develop skin cancer in the course of a lifetime.4 • The sun is the primary source of excessive ultraviolet (UV) radiation, which is the cause of most skin cancers. Immediate adverse effects of excessive exposure are sunBurn and eye damage; longer effects include premature aging of the skin and skin cancer.5 • It is estimated that more than 3.5 million new cases of Basal cell or squamous skin cancer (nonmelanoma) and 73,870 cases of melanoma (the most serious form of skin cancer) will be diagnosed in 2015 in the U.S.6 • The incidence of many common cancers is falling, but the incidence of melanoma continues to rise significantly, at a rate faster than that of any of the seven most common cancers.7 • The American Cancer Society estimates that 13,340 people will die from skin cancer in 2015, mostly due to malignant melanoma, which is among the fastest rising cancers in the U.S.8 • Melanoma is the second most common form of cancer for young adults 15-29 years old.9 • The numBer of women under age 40 diagnosed with Basal cell carcinoma has more than douBled in the last 30 years; the squamous cell carcinoma rate for women has also increased significantly.10 • In 2006, in the 116 largest (most populous) U.S.
    [Show full text]
  • Can a Virus Cause Cancer: a Look Into the History and Significance of Oncoviruses
    UC Berkeley Berkeley Scientific Journal Title Can A Virus Cause Cancer: A Look Into The History And Significance Of Oncoviruses Permalink https://escholarship.org/uc/item/6c57612p Journal Berkeley Scientific Journal, 14(1) ISSN 1097-0967 Author Rwazavian, Niema Publication Date 2011 DOI 10.5070/BS3141007638 Peer reviewed|Undergraduate eScholarship.org Powered by the California Digital Library University of California CA N A VIRU S CA U S E CA NCER ? A LOOK IN T O T HE HI st ORY A ND SIGNIFIC A NCE OF ONCO V IRU S E S Niema Rwazavian The IMPORTANC E OF ONCOVIRUS E S (van Epps 2005). Although many in the scientific Cancer, a disease caused by unregulated cell community were unconvinced of the role of viruses in growth, is often attributed to chemical carcinogens cancer, research on the subject nevertheless continued. (e.g. tobacco), hormonal imbalances (e.g. high levels of In 1933, Richard Shope discovered the first mammalian estrogen), or genetics (e.g. breast cancer susceptibility oncovirus, cottontail rabbit papillomavirus (CRPV), gene 1). While cancer can originate from any number which could infect cottontail rabbits, and in 1936, John of sources, many people fail to recognize another Bittner discovered the mouse mammary tumor virus important etiology: oncoviruses, or cancer-causing (MMTV), which could be transmitted from mothers to pups via breast milk (Javier and Butle 2008). By the 1960s, with the additional “…despite limited awareness, oncoviruses are discovery of the murine leukemia BSJ virus (MLV) in mice and the SV40 nevertheless important because they represent virus in rhesus monkeys, researchers over 17% of the global cancer burden.” began to acknowledge the possibility that viruses could be linked to human cancers as well.
    [Show full text]
  • Chemicals, Cancer, and You
    Chemicals, Cancer, and You There are many risk factors for cancer: age, family history, viruses and bacteria, lifestyle (behaviors), and contact with (touching, eating, drinking, or breathing) harmful substances. More than 100,000 chemicals are used by Americans, and about 1,000 new chemicals are introduced each year. These chemicals are found in everyday items, such as foods, personal products, packaging, prescription drugs, and household and lawn care products. While some chemicals can be harmful, not all contact with chemicals is dangerous to your health. This booklet will discuss the relationship between contact with harmful chemicals, cancer, and you. It will explain risk factors (things that make you likelier to get cancer), how cancer develops, and how contact with (exposure to) chemicals affects your body. Agency for Toxic Substances and Disease Registry Division of Health Assessment and Consultation CS218078-A 1 Chemicals, Cancer, and You Some factors that increase your risk of developing cancer include behaviors such as smoking, heavy alcohol Examples of Known Human Carcinogens consumption, on-the-job exposure to chemicals, radiation and sun exposure, and some viruses and bacteria. When all these risks are considered together, the role of chemical • Asbestos exposures in causing cancer is small and, as of now, not very clear. Scientists know very little about how contact with • Arsenic most chemicals causes cancer. • Benzene Substances known to cause cancer are called carcinogens. Coming into contact with a carcinogen does not mean you • Beryllium will get cancer. It depends on what you were exposed to, how often you were exposed, and how much you were • Vinyl chloride exposed to, among other things.
    [Show full text]
  • Occupational Cancer - Prevention and Control
    OCCUPATIONAL SAFETY AND HEALTH SERIES No. 33 OCCUPATIONAL CANCER - PREVENTION AND CONTROL INTERNATIONAL LABOUR OFFICE - GENEVA ISBN 92-2-101827-X First published 1977 The designations employed in ILO publications, which are in conformity with United Nations practice, and the presentation of material therein do not imply the expression of any opinion whatsoever on the part of the International Labour Office concerning the legal status of any country or territory or of its authorities, or concerning the delimitation of its frontiers. The responsibility for opinions expressed in signed articles, studies and other contributions rests solely with their authors, and publication does not constitute an endorsement by the International Labour Office of the opinions expressed in them. ILO publications can be obtained through major booksellers or ILO local offices in many countries, or direct from ILO Publications, International Labour Office, CH-1211 Geneva 22, Switzerland. A catalogue or list of new publications will be sent free of charge from the above address. Printed by the International Labour Office, Geneva. Switzerland. CONTENTS £âSÊ FOREWORD 1 1. PROBLEMS RELATING TO THE ESTABLISHHENT OF OCCUPATIONAL STANDARDS FOR CARCINOGENS 3 1.1 Animal experimentation 3 1.2 Extrapolation from animal to man 5 1.3 Epidemiological studies 7 1.4 New chemicals and chemicals in use 8 2. CLASSIFICATION OF CARCINOGENS FOR THE PURPOSE OF LEGISLATION 10 3. PREVENTIVE MEASURES 13 3.1 General principles 13 3.2 Technical measures 14 3.3 Personal protective measures 16 3.4 Emergencies 17 4. EXPOSURE MONITORING 18 4.1 Workplace monitoring 18 4.2 Biological monitoring 19 5.
    [Show full text]
  • V=Thr1yokvdtk the Following Content Is Provided Under a Creative Commons License
    MITOCW | watch?v=THR1YOKVdtk The following content is provided under a Creative Commons license. Your support will help MIT OpenCourseWare continue to offer high quality educational resources for free. To make a donation or view additional materials from hundreds of MIT courses, visit MIT OpenCourseWare at ocw.mit.edu. PROFESSOR: Last time I told you about oncogenes. Oncogenes-- we discussed the fact that these were gain of function mutations that occur in cancer cells-- that occur in normal cells as they develop into cancer cells, and then occur in cancer cells. And we discussed the fact that these are dominant mutations. And this was exemplified by the Weinberg experiment in which he transferred a dominant oncogene into a "normal cell' and caused that cell to become transformed despite the fact that it had normal copies of the same gene in its genome-- definition of a dominant mutation. We also talked about tumor suppressor genes. And tumor suppressor genes importantly, carry within them loss of function mutations in the context of cancer. Loss of function mutations, as such, these mutations are recessive mutations at the cellular level. It's necessary to inactivate both copies of a tumor suppressor gene in order to give rise to a cell that's lacking that function altogether. And that's a cell that is on its way to becoming a cancer cell. And these loss of function mutations can be various. You might find nonsense mutations in a tumor suppressor gene-- blocks the production of the protein. You might find a deletion. It takes out the entire gene, or a big portion of the gene.
    [Show full text]
  • Preventing and Controlling Oral and Pharyngeal Cancer
    August 28, 1998 / Vol. 47 / No. RR-14 TM Recommendations and Reports Preventing and Controlling Oral and Pharyngeal Cancer Recommendations from a National Strategic Planning Conference U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Atlanta, Georgia 30333 The MMWR series of publications is published by the Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Hu- man Services, Atlanta, GA 30333. SUGGESTED CITATION Centers for Disease Control and Prevention. Preventing and controlling oral and pharyngeal cancer. Recommendations from a national strategic planning confer- ence. MMWR 1998;47(No. RR-14):[inclusive page numbers]. Centers for Disease Control and Prevention................................ Claire V. Broome, M.D. Acting Director The material in this report was prepared for publication by National Center for Chronic Disease Prevention and Health Promotion.................................................. James S. Marks, M.D., M.P.H. Director Division of Oral Health.............................................. William R. Maas, D.D.S., M.P.H. Director The production of this report as an MMWR serial publication was coordinated in Epidemiology Program Office............................................Barbara R. Holloway, M.P.H. Acting Director Office of Scientific and Health Communications ......................John W. Ward, M.D. Director Editor, MMWR Series Recommendations and Reports................................... Suzanne M. Hewitt, M.P.A. Managing Editor Elizabeth L. Hess Project Editor Peter M. Jenkins Visual Information Specialist Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. Copies can be purchased from Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402-9325.
    [Show full text]